Understanding and controlling the cell cycle with natural products

Chemistry and Biology

Volumn 3, Issue 8, 1996, Pages 623-639

  Hung, Deborah T ^a   Jamison, Timothy F ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0030221053     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(96)90129-5     Document Type: Review

References (148)

1. Brown, E.J., Beal, P.A., Keith, C.T., Chen, J., Shin, T.B. & Schreiber, S.L. (1995). Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 377, 441-446.
2. Beishaw, P.J., Ho, S.N., Crabtree, G.R. & Schreiber, S.L. (1996). Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl. Acad. Sci. USA 93, 4604-4607.
3. Combs, A.P., Kapoor, T.M., Feng, S, Chen, J.K., Daude-Snow, L.F. & Schreiber, S.L. (1996). Protein structure-based design of combinatorial libraries: discovery of non-peptide binding elements to Src SH3 domain. J. Am. Chem. Soc. 118, 287-288.
4. Murray, A. & Hunt, T. (1993). The Cell Cycle. W. H. Freeman, New York.
5. Williams, G.T. & Smith, C.A. (1993). Molecular regulation of apoptosis: genetic controls on cell death. Cell 74, 777-779.
6. Wyllie, A.H., Kerr, J.F. & Currie, A.R. (1980). Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
7. Hunter, T. (1993). Braking the cycle. Cell 75, 839-841.
8. McKinney, J.D. & Heintz, N. (1991). Transcriptional regulation in the eukaryotic cell cycle. Trends Biochem. Sci. 16, 430-435.
9. Joshi, H.C., Palacios, M.J., McNamara, L & Cleveland, D.W. (1992). Gamma-tubulin is a centrosomal protein required for cell cycle dependent microtubule nucleation. Nature 356, 80-83.
10. Doheny, K.F., Sorger, P.K., Hyman, A.A., Tugendreich, S., Spencer, F. & Hieter, P. (1993). Identification of essential components of the S. cerevisiae kinetochore. Cell 73, 761-774.
11. Murray, A.W. (1992). Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359, 599-604.
12. Hartwell, L.H. & Weinert, T.A. (1989). Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634.
13. Johnston, G.C., Pringle, J.R. & Hartwell, L.H. (1977). Coordination of growth with cell division in the yeast Saccharomyces cerevisiae. Exp. Cell. Res. 105, 79-98.
14. Weinert, T.A. & Hartwell, L.H. (1988). The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241, 317-322.
15. Shinohara, A., Ogawa, H. & Ogawa, T. (1992). Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69, 457-470.
16. Chen, P.L., Chen, Y.M., Bookstein, R. & Lee, W.H. (1990). Genetic mechanisms of tumor suppression by the human p53 gene. Science 250, 1576-1580.
17. Vogelstein, B. & Kinzler, K.W. (1992). p53 function and dysfunction. Cell 70, 523-526.
18. Nasmyth, K. & Hunt, T. (1993). Cell cycle. Dams and sluices. Nature 366, 634-635.
19. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1-cyclin-dependent kinases. Cell 75, 805-816.
20. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. & Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
21. Polyak, K., et al., & Massague, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
22. Toyoshima, H. & Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
23. Dasso, M. & Newport, J.W. (1990). Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus. Cell 61, 811-823.
24. Downes, C.S., Clarke, D.J., Mullinger, A.M., Gimenez Abian, J.F., Creighton, A.M. & Johnson, R.T. (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372, 467-470.
25. Heck, MM, Hittelman, W.N. & Earnshaw, W.C. (1988). Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85, 1086-1090.
26. Rieder, C.L., Cole, R.W., Khodjakov, A. & Sluder, G. (1995). The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J. Cell Biol. 130, 941-948.
27. Ullrich, A. & Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
28. Cantley, L.C., et al., & Soltoff, S. (1991). Oncogenes and signal transduction. Cell 64, 281-302.
29. Liu, J., Farmer, J.D., Jr., Lane, W.S., Friedman, J., Weissman, I. & Schreiber, S.L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
30. Schreiber, S.L. (1992). Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 70, 365-368.
31. v-src protein kinase both in vivo and in vitro by radicicol. Cancer Res. 52, 6926-6930.
32. Sonoda, T., Osada, H., Uramoto, M., Uzawa, J. & Isono, K. (1989). Epiderstatin, a new inhibitor of the mitogenic activity induced by epidermal growth factor. II. Structure elucidation. J. Antibiot. (Tokyo) 42, 1607-1609.
33. Osada, H., Koshino, H., Isono, K., Takahashi, H. & Kawanishi, G. (1991). Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. J. Antibiot. (Tokyo) 44, 259-261.
34. Brown, E.J., et al., & Schreiber, S.L. (1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758.
35. Sabatini, D.M., Erdjument Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994). RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35-43.
36. Kunz, J., Henriquez, R., Schneider, U., Deuter Reinhard, M., Movva, N.R. & Hall, M.N. (1993). Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585-596.
37. Haghighat, A., Mader, S., Pause, A. & Sonenberg, N. (1995). Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14, 5701-5709.
38. Cheatham, B., Vlahos, C.J., Cheatham, L., Wang, L., Blenis, J. & Kahn, C.R. (1994). Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14, 4902-4911.
39. S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71-75.
40. Yano, H., et al., & Matsuda, Y. (1993). Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268, 25846-25856.
41. Calvo, V., Crews, C.M., Vik, T.A. & Bierer, B.E. (1992). Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA 89, 7571-7575.
42. Kuo, C.J., Chung, J., Fiorentino, D.F., Flanagan, W.M., Blenis, J. & Crabtree, G.R. (1992). Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358, 70-73.
43. Chung, J., Kuo, C.J., Crabtree, G.R. & Blenis, J. (1992). Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70-kD S6 protein kinases. Cell 69, 1227-1236.
44. Quesney-Huneeus, V., Galick, H.A., Siperstein, M.D., Erickson, S.K., Spencer, T.A. & Nelson, J.A. (1983). The dual role of mevalonate in the cell cycle. J. Biol. Chem. 258, 378-385.
45. Quesney Huneeus, V., Wiley, M.H. & Siperstein, M.D. (1979). Essential role for mevalonate synthesis in DNA replication. Proc. Natl. Acad. Sci. USA 76, 5056-5060.
46. Dawson, M.J. et al., & Hayes, M.V. (1992). The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. (Tokyo) 45, 639-647.
47. Langan, T.J. & Volpe, J.J. (1987). Cell-cycle-specific requirement for mevalonate, but not for cholesterol, for DNA synthesis in glial primary cultures. J. Neurochem. 49, 513-521.
48. Langan, T.J. & Slater, M.C. (1991). Isoprenoids and astroglial cell cycling: diminished mevalonate availability and inhibition of dolichol-linked glycoprotein synthesis arrest cycling through distinct mechanisms. J. Cell. Physiol. 149, 284-292.
49. Ishii, S. & Volpe, J.J. (1987). Dolichol-linked glycoprotein synthesis in G1 is necessary for DNA synthesis in synchronized primary cultures of cerebral glia. J. Neurochem. 49, 1606-1612.
50. Lennarz, W.J. (1985). Regulation of glycoprotein synthesis during development of the sea urchin embryo. Dev. Biol. 3, 59-79.
51. Larsson, O. & Zetterberg, A. (1986). Effects of 25-hydroxycholesterol, cholesterol, and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells. J. Cell. Physiol. 129, 94-102.
52. Doyle, J.W. & Kandutsch, A.A. (1988). Requirement for mevalonate in cycling cells: quantitative and temporal aspects. J. Cell. Physiol. 137, 133-140.
53. Huneeus, V.Q., Wiley, M.H. & Siperstein, M. D. (1980). Isopentenyladenine as a mediator of mevalonate-regulated DNA replication. Proc. Natl. Acad. Sci. USA 77, 5842-5846.
54. Kohl, N.E., et al., & Gibbs, J.B. (1993). Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260, 1934-1937.
55. James, G.L., et al., & Marsters, J.C., Jr. (1993). Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260, 1937-1942.
56. Calabresi, P. & Parks, R.E. (1985) Chemotherapy of neoplastic diseases. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. (Hardman, J.G.G., Gilman, A. & Limbird, L.L., eds), pp 1240-1306, MacMillan, New York.
57. Schlegel, R. & Pardee, A.B. (1986). Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science 232, 1264-1266.
58. Raff, J.W. & Glover, D.M. (1988). Nuclear and cytoplasmic mitotic cycles continue in Drosophila embryos in which DNA synthesis is inhibited with aphidicolin. J. Cell. Biol. 107, 2009-2019.
59. Gilbert, D.M., Neilson, A., Miyazawa, H., DePamphilis, M.L. & Burhans, W.C. (1995). Mimosine arrests DNA synthesis at replication forks by inhibiting deoxyribonucleotide metabolism. J. Biol. Chem. 270, 9597-9606.
60. Nicolaou, K.C. & Dai, W.M. (1991). Chemistry and biology of enediyne-cytostatic antibiotics. Angew. Chem. Int. Ed. Engl. 30, 1387-1416.
61. Goldberg, I.H. (1991). Mechanism of neocarzinostatin action: role of DNA microstructure in determination of chemistry of bistranded oxidative damage. Acc. Chem. Res. 24, 191-198.
62. Stubbe, J. & Kozarich, J.W. (1987). Mechanisms of bleomycin-induced DNA degradation. Chem. Rev. 87, 1107-1136.
63. Huang, J.C., Zamble, D.B., Reardon, J.T., Lippard, S.J. & Sancar, A. (1994). HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. USA 91, 10394-10398.
64. Takahara, P.M., Rosenzweig, A.C., Frederick, C.A. & Lippard, S.J. (1995). Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377, 649-652.
65. Mello, J.A., Acharya, S., Fishel, R. & Essigmann, J.M. (1996). The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chemistry & Biology 3, 579-589.
66. Canman, C.E., Wolff, A.C., Chen, C.Y., Fornace, A.J., Jr. & Kastan, M.B. (1994). The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54, 5054-5058.
67. Nelson, W.G. & Kastan, M.B. (1994). DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14, 1815-1823.
68. Belenguer, P., Oustrin, M.L., Tiraby, G. & Ducommun, B. (1995). Effects of phleomycin-induced DNA damage on the fission yeast Schizosaccharomyces pombe cell cycle. Yeast 11, 225-231.
69. Medrano, E.E. & Pardee, A.B. (1980). Prevalent deficiency in tumor cells of cycloheximide-induced cycle arrest. Proc. Natl. Acad. Sci. USA 77, 4123-4126.
70. Hershko, A., Ganoth, D., Pehrson, J., Palazzo, R.E. & Cohen, L.H. (1991). Methylated ubiquitin inhibits cyclin degradation in clam embryo extracts. J. Biol. Chem. 266, 16376-16379.
71. Glotzer, M., Murray, A.W. & Kirschner, M.W. (1991). Cyclin is degraded by the ubiquitin pathway. Nature 349, 132-138.
72. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E.J. & Schreiber, S.L. (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268, 726-731.
73. Fenteany, G., Standaert, R.F., Reichard, G.A., Corey, E.J. & Schreiber, S.L. (1994). A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. USA 91, 3358-3362.
74. Vesely, J., et al., & Meijer, L. (1994). Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224, 771-786.
75. Abe, K., Yoshida, M., Usui, T., Horinouchi, S. & Beppu, T. (1991). Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Exp. Cell. Res. 192, 122-127.
76. Lin, Y., Chrest, F.J. & Gabrielson, E.W. (1992). Reversible G1 arrest of a human lung epithelial cell line by staurosporine. J. Cell. Physiol. 152, 646-653.
77. Gong, J., Traganos, F. & Darzynkiewicz, Z. (1994). Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points. Cancer Res. 54, 3136-3139.
78. cdc2-like kinases. Biochem. Biophys. Res. Commun. 184, 80-85.
79. Seynaeve, C.M., et al., & Worland, P.J. (1993). Cell-cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Cancer Res. 53, 2081-2086.
80. Yoshida, M., Yamamoto, M. & Nikaido, T. (1992). Quercetin arrests human leukemic T cells in late G1 phase of the cell cycle. Cancer Res. 52, 6676-6681.
81. Hofmann, J., et al., & Grunicke, H. (1994). The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents. Biochem. Biophys. Res. Commun. 199, 937-943.
82. Levin, D.E., Fields, F.O., Kunisawa, R., Bishop, J.M. & Thorner, J. (1990). A candidate protein kinase C gene, PKC1, is required for the S. cerevisiae cell cycle. Cell 62, 213-224.
83. Ohno, S., et al., & Suzuki, K. (1991). Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC. Adv. Enzyme Regul. 31, 287-303.
84. Pettit, G.R. (1991). The bryostatins. Prag. Chem. Org. Nat. Prod. 57, 153-195.
85. Fujiki, H. & Sugimura, T. (1987). New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Adv. Cancer Res. 49, 223-264.
86. Driedger, P.E. & Blumberg, P.M. (1980). Different biological targets for resiniferatoxin and phorbol 12-myristate 13-acetate. Cancer Res. 40, 1400-1404.
87. Yoshida, M., Horinouchi, S. & Beppu, T. (1995). Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423-430.
88. Taunton, J., Hassig, C.A. & Schreiber, S.L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
89. Heby, O., Marton, L.J., Wilson, C.B. & Gray, J.W. (1977). Effect of methylglyoxal-bis (guanylhydrazone), an inhibitor of spermidine and spermine synthesis, on cell cycle traverse. Eur. J. Cancer 13, 1009-1017.
90. Flink, I. & Pettijohn, D.E. (1975). Polyamines stabilise DNA folds. Nature 253, 62-63.
91. Chiu, J.F. & Sung, S.C. (1972). Effect of spermidine on the activity of DNA polymerases. Biochim. Biophys. Acta 281, 535-542.
92. Rani, C.S., et al., & Shayman, J.A. (1995). Cell-cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J. Biol. Chem. 270, 2859-2867.
93. Zhang, H., Desai, N.N., Olivera, A., Seki, T., Brooker, G. & Spiegel, S. (1991). Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114, 155-167.
94. Hannun, Y.A., Obeid, L.M. & Wolff, R.A. (1993). The novel second messenger ceramide: identification, mechanism of action, and cellular activity. Adv. Lipid Res. 25, 43-64.
95. Obeid, L.M., Linardic, C.M., Karolak, L.A. & Hannun, Y.A. (1993). Programmed cell death induced by ceramide. Science 259, 1769-1771.
96. Miyake, Y., Kozutsumi, Y., Nakamura, S., Fujita, T. & Kawasaki, T. (1995). Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem. Biophys. Res. Commun. 211, 396-403.
97. Horvath, A., Sutterlin, C., Manning-Krieg, U., Movva, N.R. & Riezman, H. (1994). Ceramide synthesis enhances transport of GPI-anchored proteins to the Golgi apparatus in yeast. EMBO J. 13, 3687-3695.
98. Spinozzi, F., et al., & Nicoletti, I. (1994). The natural tyrosine kinase inhibitor genistein produces cell-cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk. Res. 18, 431-439.
99. Obinata, A., Akimoto, Y., Hirano, H. & Endo, H. (1991). Stimulation by Bt2cAMP of epidermal mucous metaplasia in retinol-pretreated chick embryonic cultured skin, and its inhibition by herbimycin A, an inhibitor for protein-tyrosine kinase. Exp. Cell Res. 193, 36-44.
100. Potmesil, M., et al., & Silber, R. (1988). Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res. 48, 3537-3543.
101. Sinha, B.K. (1995). Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs 49, 11-19.
102. Roca, J., Ishida, R., Berger, J.M., Andoh, T. & Wang, J.C. (1994). Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl. Acad. Sci. USA 91, 1781-1785.
103. Giese, G., Wiegers, W., Kubbies, M., Scherbarth, A. & Traub, P. (1995). Okadaic acid coinduces vimentin expression and cell-cycle arrest in MPC-11 mouse plasmacytoma cells. J. Cell Physiol. 163, 145-154.
104. Afshari, C.A. & Barrett, J.C. (1994). Disruption of G0-G1 arrest in quiescent and senescent cells treated with phosphatase inhibitors. Cancer Res. 54, 2317-2321.
105. Takizawa, P.A., et al., & Malhotra, V. (1993). Complete vesiculation of Golgi membranes and inhibition of protein transport by a novel sea sponge metabolite, ilimaquinone. Cell 73, 1079-1090.
106. Fournier, R.E. & Pardee, A.B. (1975). Cell-cycle studies of mononucleate and cytochalasin-B-induced binucleate fibroblasts. Proc. Natl. Acad. Sci. USA 72, 869-873.
107. Martineau, S.N., Andreassen, P.R. & Margolis, R.L. (1995). Delay of HeLa cell cleavage into interphase using dihydrocytochalasin B: retention of a postmitotic spindle and telophase disk correlates with synchronous cleavage recovery. J. Cell Biol. 131, 191-205.
108. Uppuluri, S., Knipling, L., Sackett, D.L. & Wolff, J. (1993). Localization of the colchicine-binding site of tubulin. Proc. Natl. Acad. Sci. USA 90, 11598-11602.
109. Cortese, F., Bhattacharyya, B. & Wolff, J. (1977). Podophyllotoxin as a probe for the colchicine binding site of tubulin. J. Biol. Chem. 252, 1134-1140.
110. Hoebeke, J., Van Nijen, G. & De Brabander, M. (1976). Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem. Biophys. Res. Commun. 69, 319-324.
111. Lee, J.C., Harrison, D. & Timasheff, S.N. (1975). Interaction of vinblastine with calf brain microtubule protein. J. Biol. Chem. 250, 9276-9282.
112. Kupchan, S.M., et al., & Bryan, R.F. (1972). Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J. Am. Chem. Soc. 94, 1354-1356.
113. Luduena, R.F., Roach, M.C., Prasad, V. & Pettit, G.R. (1993). Interaction of halichondrin B and homohalichondrin B with bovine brain tubulin. Biochem. Pharmacol. 45, 421-427.
114. Luduena, R.F., et al., & Iwasaki, S. (1994). Interaction of ustiloxin A with bovine brain tubulin. Biochem. Pharmacol. 47, 1593-1599.
115. Bai, R., Cichacz, Z.A., Herald, C.L., Pettit, G.R. & Hamel, E. (1993). Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol. Pharmacol. 44, 757-766.
116. Dahllof, B., Billstrom, A., Cabrai, F. & Hartley-Asp, B. (1993). Estramustine depolymerizes miorotubules by binding to tubulin. Cancer Res. 53, 4573-4581.
117. Margolis, R.L., Rauch, C.T. & Wilson, L. (1980). Mechanism of colchicine-dimer addition to microtubule ends: implications for the microtubule polymerization mechanism. Biochemistry 19, 5550-5557.
118. Nicolaou, K.C., Dai, W.M. & Guy, R.K. (1994). Chemistry and biology of taxol. Angew. Chem. Int. Ed. Engl. 33, 15-44.
119. Jordan, M.A., Toso, R.J., Thrower, D. & Wilson, L (1993). Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl. Acad. Sci. USA 90, 9552-9556.
120. Rieder, C.L., Schultz, A., Cole, R. & Sluder, G. (1994). Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J. Cell Biol. 127, 1301-1310.
121. Nogales, E., Wolf, S.G., Khan, I.A., Luduena, R.F. & Downing, K.H. (1995). Structure of tubulin at 6.5 Å and location of the taxol-binding site. Nature 375, 424-427.
122. Andreu, J.M., et al., & Bordas, J. (1994). Solution structure of Taxotere-induced microtubules to 3-nm resolution. The change in protofilament number is linked to the binding of the taxol side chain. J. Biol. Chem. 269, 31785-31792.
123. Andreu, J.M., et al., & Towns-Andrews, E. (1992). Low resolution structure of microtubules in solution. Synchrotron X-ray scattering and electron microscopy of taxol-induced microtubules assembled from purified tubulin in comparison with glycerol and MAP-induced microtubules. J. Mol. Biol. 226, 169-184.
124. Rao, S., et al., & Horwitz, S.B. (1994). 3′-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β tubulin. J. Biol. Chem. 269, 3132-3134.
125. ter Haar, E., et al., & Day, B.W. (1996). Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 35, 243-250.
126. Hung, D.T., Chen, J. & Schreiber, S.L. (1996). (+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest. Chemistry & Biology 3, 287-293.
127. Bollag, D.M., et al., & Woods, C.M. (1995). Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55, 2325-2333.
128. David, B., et al., & Wright, M. (1994). Rhazinilam mimics the cellular effects of taxol by different mechanisms of action. Cell Motil. Cytoskeleton 28, 317-326.
129. Grisham, L.M., Wilson, L. & Bensch, K.G. (1973). Antimitotic action of griseofulvin does not involve disruption of microtubules. Nature 244, 294-296.
130. Weber, K., Wehland, J. & Herzog, W. (1976). Griseofulvin interacts with microtubules both in vivo and in vitro. J. Mol. Biol. 102, 817-829.
131. Kung, A.L., Zetterberg, A., Sherwood, S.W. & Schimke, R.T. (1990). Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Res. 50, 7307-7317.
132. Sakai, T., Aoike, A., Marui, N., Kawai, K., Nishino, H. & Fukushima, M. (1989). Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells. Cancer Res. 49, 1193-1196.
133. Donaldson, K.L., Goolsby, G.L., Kiener, P.A. & Wahl, A.F. (1994). Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differentiation 5, 1041-1050.
134. Xu, C., Meikrantz, W., Schlegel, R. & Sager, R. (1995). The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proc. Natl. Acad. Sci. USA 92, 7829-7833.
135. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967.
136. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. & Oren, M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347.
137. Keith, C.T. & Schreiber, S.L. (1995). PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270, 50-51.
138. Kastan, M.B., et al., & Fornace, A.J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71, 587-597.
139. Albers, M.W., Williams, R.T., Brown, E.J., Tanaka, A., Hall, F.L. & Schreiber, S.L. (1993). FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J. Biol. Chem. 268, 22825-22829.
140. Gong, J., Traganos, F. & Darzynkiewicz, Z. (1995). Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. Exp. Cell Res. 220, 226-231.
141. Nadler, S.G., Tepper, M.A., Schacter, B. & Mazzucco, C.E. (1992). Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 258, 484-486.
142. Shimada, J., Kwon, H.J., Sawamura, M. & Schreiber, S.L. (1995). Synthesis and cellular characterization of the detransformation agent, (-)-depudecin. Chemistry & Biology 2, 517-525.
143. Crews, C.M., Collins, J.L., Lane, W.S., Snapper, M.L. & Schreiber, S.L. (1994). GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1α. J. Biol. Chem. 269, 15411-15414.
144. SirDeshpande, B.V. & Toogood, P.L. (1995). Mechanism of protein synthesis inhibition by didemnin B in vitro. Biochemistry 34, 9177-9184.
145. Crews, C.M., Lane, W.S. & Schreiber, S.L. (1996). Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis. Proc. Natl. Acad. Sci. USA 93, 4316-4319.
146. Nishi, K., Yoshida, M., Fujiwara, D., Nishikawa, M., Horinouchi, S. & Beppu, T. (1994). Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269, 6320-6324.
147. Kinnel, R.B. & Gehrken, H.P. (1993). Palau'amine: a cytotoxic and immunosuppressive hexacyclic bisguanidine antibiotic from the sponge Stylotella agminata. J. Am. Chem. Soc. 115, 3376-3377.
148. Lindquist, N., Fenical, W., Van Duyne, G.D. & Clardy, J. (1991). Isolation and structure determination of diazonamides A and B, unusual cytotoxic metabolites from the marine ascidian Diazona chinensis. J. Am. Chem. Soc. 113, 2303-2304.